Prostate News Archive
04-Oct-2006
Prostate Test Helps Choice of Cancer Treatments, Scientists Say (Bloomberg.com)
Oct. 4 (Bloomberg) -- prostate tests may help determine whether men suffering cancer of the gland can avoid immediate post-surgery treatment that increases the risk of impotence and other side effects, scientists in Australia said. Cialis Improves Sexual Function For Prostate Cancer Survivors (Science Daily)
In the first randomized trial of its kind, Tadalafil, a drug typically prescribed for erectile dysfunction in men, has been proven to increase the sexual function of prostate cancer survivors, according to a study released today from the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO. Alcohol does not affect prostate cancer risk (Reuters via Yahoo! News)
Drinking does not appear to be associated with the overall incidence of prostate cancer, according to findings published in the International Journal of Cancer. However, men who drink alcohol may have a lower risk of having an aggressive prostate cancer and dying from this cancer. Spectrum prostate drug promising in mid-stage study (The Globe and Mail)
NEW YORK (Reuters) - Spectrum Pharmaceuticals Inc. on Tuesday said its experimental drug to treat noncancerous enlarged prostate was highly effective in reducing symptoms associated with the condition called benign prostate hypertrophy (BPH) in a mid-stage clinical trial. Gene clues in prostate treatment (Townsville Bulletin)
A GENE which gives men with prostate cancer a life-saving clue about whether their disease will spread has been uncovered by Australian scientists. One in five men who have their prostate removed because of cancer will develop the disease in another part of their body in the following decade. Test Could Spot Aggressive Prostate Cancer (HealthDay via Yahoo! News)
TUESDAY, Oct. 3 (HealthDay News) -- Australian researchers say they've found a new marker for identifying aggressive prostate cancer. Spectrum says prostate drug promising in mid-stage (Reuters via Yahoo! Asia News)
NEW YORK (Reuters) - Spectrum Pharmaceuticals Inc. said on Tuesday its experimental drug to treat noncancerous enlarged prostate was highly effective in reducing symptoms associated with the condition called benign prostate hypertrophy (BPH) in a mid-stage clinical trial. Prostate cancer clue uncovered (The West Australian)
A gene which gives men with prostate cancer a lifesaving clue about whether their disease will spread has been uncovered by Australian scientists. One in five men who have their prostate removed because of cancer will develop the disease in another part of their body in the following decade.
Back to Prostate News Archive
